About NinePoint Medical
NinePoint Medical improves patient care through the development of medical devices that enable high-resolution in-vivo imaging. Using advanced optical technologies, NinePoint Medical empowers treating physicians and pathologists to image cross-sectionally to visualize features at and below the mucosal surface, over very large areas. The company delivers imaging information to support clinical decision-making relative to biopsy placement and treatment planning.
NinePoint Medical Patents
NinePoint Medical has filed 25 patents.
Interferometers, Interferometry, Laser medicine, Optical imaging, Photonics
Interferometers, Interferometry, Laser medicine, Optical imaging, Photonics
Latest NinePoint Medical News
May 25, 2021
May 01, 2018 08:19 AM Eastern Daylight Time BEDFORD, Mass.--( BUSINESS WIRE )-- NinePoint Medical, Inc , a transformative medical device company pioneering the use of Optical Coherence Tomography (OCT) for gastrointestinal applications, today announced a long-term strategic partnership with Merit Medical Systems, Inc. (NASDAQ: MMSI ). This partnership includes a strategic investment and a worldwide distribution agreement with Merit Medical’s endoscopic division, Merit Medical Endotek® (Endotek), for NinePoint Medical’s NvisionVLE® Imaging System with Real-time Targeting™. This partnership combines the world-class Gastrointestinal (GI) and Pulmonary medical devices from Endotek with the ground-breaking Advanced OCT platform from NinePoint Medical. This OCT platform has, in a short period of time, become a primary imaging device used by many of the leading hospitals in the U.S. to aid in the early detection of esophageal cancer. “NinePoint Medical is committed to providing GI physicians an elegant and cost-effective OCT imaging solution to enable early and accurate diagnosis,” commented Christopher R. von Jako, Ph.D., President and Chief Executive Officer of NinePoint Medical. “Merit Medical Endotek is the ideal partner as they have the reputation, clinical experience, and complementary product portfolio to grow this business.” “We are very excited to form this partnership in order to provide NinePoint Medical’s highly innovative OCT imaging system to our customers and other clinicians around the world,” said Merit Medical System’s Chairman and Chief Executive Officer Fred P. Lampropoulos. “Endotek is a market leader in GI solutions, and we share NinePoint Medical’s vision of improving early cancer detection and thereby improving patient outcomes while reducing healthcare costs.” The NvisionVLE Imaging System provides a unique and clinically valuable new perspective on esophageal disease - the ability to image within the wall of the esophagus. By providing a high-resolution, real-time scan of the esophagus using Optical Coherence Tomography (OCT) – a technology similar to ultrasound but using infrared light rather than sound waves - the system enables physicians to view structures not evident with conventional imaging, and potentially identify disease that would have otherwise been missed. With the recent addition of a Real-time TargetingTM feature, physicians can not only locate, but now mark areas of interest. This marking feature, in combination with an improved workflow, enables more accurate targeting, potentially leading to improved diagnosis and more effective therapeutic decisions for patients. The NvisionVLE® Imaging System has been cleared by the FDA and is commercially available in the U.S. It is indicated for use as an imaging tool in the evaluation of human tissue microstructure, including esophageal tissue microstructure, by providing two-dimensional, cross-sectional, real-time depth visualization and may be used to mark areas of tissue. The safety and efficacy of this device for diagnostic analysis (i.e. differentiating normal versus specific abnormalities) in any tissue microstructure or specific disease has not been evaluated. NinePoint Medical is a privately-held medical device company that designs, manufactures, and sells an Optical Coherence Tomography (OCT) imaging platform for clinical use in gastroenterology, pulmonology, urology, gynecology, and ENT, for the evaluation of human tissue microstructure. Using proprietary imaging and software technology, the Company is committed to enabling quicker diagnosis of disease and more effective treatments, while reducing the overall cost of healthcare. NinePoint Medical is located in suburban Boston, Massachusetts. For more information, please visit www.ninepointmedical.com . Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force totaling approximately 290 individuals. Merit employs approximately 5,000 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; San Jose, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; and Yishun, Singapore.
NinePoint Medical Frequently Asked Questions (FAQ)
Where is NinePoint Medical's headquarters?
NinePoint Medical's headquarters is located at 12 Oak Park Drive, Bedford.
What is NinePoint Medical's latest funding round?
NinePoint Medical's latest funding round is Dead.
How much did NinePoint Medical raise?
NinePoint Medical raised a total of $97.98M.
Who are the investors of NinePoint Medical?
Investors of NinePoint Medical include Merit Medical Systems, Third Rock Ventures, Prospect Venture Partners, Corning and Massachusetts Life Sciences Center.
Who are NinePoint Medical's competitors?
Competitors of NinePoint Medical include BioProtect, Itamar Medical, Simbionix, GENICON, Sphere Medical and 7 more.
Compare NinePoint Medical to Competitors
Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment. Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.
MST - Medical Smart Tools was founded in 2004 with the mission to develop image guided surgery technology solutions. The Company aims to improve laparoscopic and other minimally invasive surgical procedures and medical staff effectiveness, thus increasing hospital efficiencies, reducing surgical costs, and improving patient outcomes. MST is working within NGT, a private technological incubator in Nazareth, Israel. MST presents the market with a smart disposable Robotic Arm camera holder for laparoscopy, based on advanced image technology. The system is comprised of a computer-controlled mechanism for mechanical camera motivation, intuitive interface between the surgeon and the mechanical system. The company's R&D efforts are spearheaded by a core group of engineers with expertise in image processing, dynamics of mechanisms, multi-link systems and biomechanics. The Company is backed by strong and experienced management and professional medical advisors.
BioProtect develops radiation protection technology in the healthcare industry. The company offers biodegradable balloon spacers that create a safe distance between the prostate and rectum during radiation therapy, reducing radiation exposure to healthy tissue. It serves the oncology sector, with a particular emphasis on prostate cancer treatment. The company was founded in 2004 and is based in Tzur Yigal, Israel.
Magnetecs is a company that focuses on the design and manufacture of medical technology, specifically within the healthcare industry. The company's main product is a robotic Catheter Guidance Control and Imaging (CGCI) system, which is used for minimally invasive medical procedures. This system uses an electromagnetic array to guide a magnetically-tipped catheter, allowing physicians to control surgical tools with precision and consistency, enhancing safety and dexterity. It is based in Inglewood, California.
Gynesonics women's healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids. It develops the sonata system for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance. The sonata system uses radiofrequency energy to ablate fibroids under intrauterine sonography guidance. Gynesonics was founded in 2005 and is based in Redwood City, California.
Cambridge Endoscopic Devices (CED) has developed a line of surgical instruments that aim to address the need for enhanced dexterity and manipulation in laparoscopic and endoscopic surgery. Per the company, these instruments overcome surgical barriers encountered with traditional endoscopic and laparoscopic instruments, allowing for the potential of new surgical procedures and better, more cost effective clinical outcomes.